Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

MSE PRO 1-Boc-2-methyl-DL-proline, ≥95.0% Purity– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

MSE PRO 1-Boc-2-methyl-DL-proline, ≥95.0% Purity - MSE Supplies LLC

MSE PRO 1-Boc-2-methyl-DL-proline, ≥95.0% Purity

SKU: CM1500

  • $ 27995
  • Save $ 3105


MSE PRO™ 1-Boc-2-methyl-DL-proline, ≥95.0% Purity

MSE PRO™ 1-Boc-2-methyl-DL-proline is a versatile and valuable synthetic building block for organic synthesis and medicinal chemistry applications. As a proline derivative, it possesses a unique rigid pyrrolidine ring structure that can impart conformational constraints and influence the biological activity of target molecules. The presence of the tert-butyloxycarbonyl (Boc) protecting group allows for selective deprotection under mild acidic conditions, revealing a reactive secondary amine functionality. This feature enables further derivatization and the controlled introduction of diverse substituents, facilitating the synthesis of complex peptidomimetics, heterocyclic compounds, and potential drug candidates.

MSE Supplies offers various N-heterocyclic drug small molecules and other chemical reagents. Please contact us for bulk orders.

Technical Specifications:

CAS No. 203869-80-1
Chemical name 1-Boc-2-methyl-DL-proline
Synonym(s)
  • 1-(tert-butoxycarbonyl)-2-methylpyrrolidine-2-carboxylic acid
  • Boc-alpha-Me-DL-Pro-OH
Molecular formula C11H19NO4                  
Pack size 5 g (CM1500)
Molecular weight 229.27 g/mol
Purity ≥95.0% (NMR)
Boiling point  337.8±35.0 °C (Predicted) 
Melting point  91-94 °C
Density   1.160±0.06 g/cm
pKa 4.20±0.20 (Predicted) 
Appearance White to off-white solid 
Storage  Store at 2-8°C


References:

[1] Boss, C., Gatfield, J., Brotschi, C., Heidmann, B., Sifferlen, T., von Raumer, M., ... & Roch, C. (2020). The quest for the best dual orexin receptor antagonist (daridorexant) for the treatment of insomnia disorders. ChemMedChem15(23), 2286-2305.

[2] Hennecke, U., Guria, S., Volkov, A. N., Khudaverdyan, R., Van Lommel, R., Daniliuc, C. G., & De Proft, F. (2023). Enantioselective Synthesis of Pyrrolidines by Imidodiphosphorimidate (IDPi)-catalysed anti-hydroamination of alkenes.